Neurosona Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 17

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

Neurosona General Information

Description

Developer of non-invasive neuromodulation devices intended to overcome the limitations of existing drugs, surgical operations, and electrical or magnetic stimulation treatments. The company offers image-guided low-intensity focused ultrasound systems, neuromodulation platforms, blood-brain barrier opening systems, 3D brain imaging and navigation software, transducer systems, clinical trial-ready devices, and treatment parameter optimization tools, enabling precise and safe stimulation of deep brain regions to support the treatment of neurological conditions.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 13th floor, 1307-1310, Tower B
  • 11 Beobwon-ro 11-gil, Songpa-gu
  • Seoul, 05836
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Devices and Supplies
Parent Company
Corporate Office
  • 13th floor, 1307-1310, Tower B
  • 11 Beobwon-ro 11-gil, Songpa-gu
  • Seoul, 05836
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurosona Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neurosona‘s full profile, request access.

Request a free trial

Neurosona Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurosona Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Neurosona‘s full profile, request access.

Request a free trial

Neurosona FAQs

  • When was Neurosona founded?

    Neurosona was founded in 2017.

  • Where is Neurosona headquartered?

    Neurosona is headquartered in Seoul, South Korea.

  • What is the size of Neurosona?

    Neurosona has 17 total employees.

  • What industry is Neurosona in?

    Neurosona’s primary industry is Drug Discovery.

  • Is Neurosona a private or public company?

    Neurosona is a Private company.

  • What is the current valuation of Neurosona?

    The current valuation of Neurosona is .

  • What is Neurosona’s current revenue?

    The current revenue for Neurosona is .

  • How much funding has Neurosona raised over time?

    Neurosona has raised $6.9M.

  • Who are Neurosona’s investors?

    DHX Company has invested in Neurosona.

  • When was Neurosona acquired?

    Neurosona was acquired on 07-May-2024.

  • Who acquired Neurosona?

    Neurosona was acquired by TS Nexgen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process